A new study confirms that the protective T cell immune response induced by COVID-19 vaccination is preserved in people treated with B cell depleting therapies for MS. This helps our understanding of how vaccinations and MS treatments affect each other.
MS Australia, the national peak body for people affected by multiple sclerosis (MS), has today congratulated Prime Minister Anthony Albanese MP and the incoming Labor Government, and reiterated its call for full and ongoing funding of the National Disability Insurance Scheme (NDIS).
With Monday, May 30 the start of the working week, our focus this World MS Day, is Employment and MS, including its important link to community connection.
A new survey has uncovered a significant disconnect between supportive community attitudes towards co-workers with health conditions, like MS, and the reality of poor experiences within workplaces.
The MS Brain Health initiative has launched an annual series of awards to illustrate the global impact of lifelong
There are over 25,600 Australians living with MS. Help us Kiss Goodbye to MS once and for all and join The May 50K today.
CEO, Rohan Greenland discusses MS Australia’s seven-point plan for the federal election, together with our biggest annual fundraiser for MS research – The May 50K.
A new vaccine combination targeting two pathways of Epstein Barr virus (EBV) entry into human cells is progressing towards clinical development, taking us one step closer to understanding the complex association between MS and EBV.
World MS Day brings the global MS community together on May 30 to share stories, raise awareness and campaign with and on behalf of everyone affected by multiple sclerosis (MS).
